Suchergebnisse - "Bosnyak, Sanja"

PubPharm (7)

1

AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts : Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis

enthalten in: Journal of the American Society of Nephrology : JASN | 2019

von Chow, B. | Kocan, M. | Shen, M. | +17

2

β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats

enthalten in: Clinical science (London, England : 1979) | 2015

von Del Borgo, M. | Wang, Y. | Bosnyak, S. | +9

3

Electronic sculpting of ligand-GPCR subtype selectivity : the case of angiotensin II

enthalten in: ACS chemical biology | 2014

von Magnani, F. | Pappas, C. | Crook, T. | +11

4

Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis

enthalten in: Kidney international | 2014

von Chow, B. | Kocan, M. | Bosnyak, S. | +8

CommentIn: Kidney Int. 2014 Jul;86(1):9-10. - PMID 24978374

5

Direct AT₂ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient mice

enthalten in: International journal of cardiology | 2013

von Kljajic, S. | Widdop, R. | Vinh, A. | +4

6

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors

enthalten in: Clinical science (London, England : 1979) | 2011

von Bosnyak, S. | Jones, E. | Christopoulos, A. | +3

7

A single beta-amino acid substitution to angiotensin II confers AT2 receptor selectivity and vascular function

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2011

von Jones, E. | Del Borgo, M. | Kirsch, J. | +9

1
[1]